For instance, treatment with pyridostigmine bromide, an AChE inhibitor used clinically for myasthenia gravis, improved outcomes in a murine Trypanosoma cruzi infection model, with effects attributed to cholinergic modulation of host immune responses [54,55]. The gene discussed is ACHE; the disease is myasthenia gravis.